Article Per Year (5 Year)
p-Index From 2021 - 2026
0.562
P-Index
This Author published in this journals
All Journal Majalah Ilmiah Warta Dharmawangsa Jurnal Kajian Islam Modern Clinical and Pharmaceutical Sciences Journal
Rozak, Miftahul
Unknown Affiliation
Religion Biochemistry, Genetics & Molecular Biology Chemistry Economics, Econometrics & Finance Education Health Professions Materials Science & Nanotechnology Medicine & Pharmacology Public Health Social Sciences

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
PENERAPAN NILAI ISLAMI DALAM PELAYANAN FARMASI KLINIS: KAJIAN SISTEMATIS ETIKA, KEHALALAN DAN KEPUASAN PASIEN Rozak, Miftahul; Saraswati, Damai Ira; Fathurohman SW, Oman; Salamah, Nina
JURNAL KAJIAN ISLAM MODERN Vol 12 No 01 (2025): MARET 2025
Publisher : Institut Agama Islam Sahid (INAIS) Bogor

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56406/jkim.v12i01.641

Abstract

Islamic pharmaceutical and healthcare services represent an innovative approach that integrates Islamic ethical values, such as justice, halal compliance, and patient satisfaction, into clinical practice. However, the application of these values faces challenges, including public knowledge gaps, insufficient training for healthcare professionals, and the lack of unified practice standards. This study employs a systematic review method to analyze relevant literature from the past decade. Literature searches were conducted using PubMed and Google Scholar with keywords such as "Islamic values in clinical pharmacy," "halal pharmaceuticals," and "maqasid shariah in healthcare." Articles meeting inclusion criteria were evaluated following PRISMA guidelines and analyzed qualitatively to identify key findings and research gaps. After the selection process, six articles met the inclusion criteria.. The findings reveal that integrating Islamic values, such as halal pharmaceuticals, Islamic ethics, and sharia-based facilities, significantly contributes to improving pharmaceutical service quality, patient satisfaction, and loyalty among Muslim patients. However, implementation remains constrained by a lack of healthcare professional training, minimal regulations, and incomplete societal perceptions. This review highlights the importance of developing an integrated framework, enhancing public and professional education, and fostering cross-professional collaboration to support the integration of Islamic values in healthcare services. This approach holds great potential to enhance service quality, patient satisfaction, and loyalty while serving as an innovative model for universal healthcare services.
PENINGKATAN PENGETAHUAN DAN SIKAP REMAJA TENTANG ANEMIA MELALUI EDUKASI GIZI DAN TABLET TAMBAH DARAH Rozak, Miftahul; Pratiwi, Tiara Bella; Heldin, Siti Salamiah Putri; Chotimah, Aditya Nurul; Susanti, Hari
Jurnal Warta Dharmawangsa Vol 19, No 4 (2025)
Publisher : Universitas Dharmawangsa

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46576/wdw.v19i4.7373

Abstract

Penelitian ini bertujuan untuk mengevaluasi efektivitas edukasi gizi dan konsumsi Tablet Tambah Darah (TTD) dalam meningkatkan pengetahuan dan sikap remaja terhadap pencegahan anemia. Kegiatan dilakukan pada siswa kelas XII MIPA 3 di SMAN 1 Sungai Kakap, Kalimantan Barat, menggunakan desain one group pretest-posttest. Materi edukasi disampaikan melalui presentasi dan interaksi langsung, kemudian diukur dampaknya melalui kuesioner sebelum dan sesudah intervensi. Hasil menunjukkan peningkatan signifikan pada aspek pengetahuan dasar tentang anemia, sikap terhadap pentingnya konsumsi TTD saat menstruasi, serta pemahaman risiko dan tindakan pencegahan anemia. Salah satu peningkatan paling mencolok adalah pada pemahaman tentang alasan konsumsi TTD, dari 48% pada pretest menjadi 100% pada posttest. Temuan ini menunjukkan bahwa intervensi edukatif mampu membentuk sikap preventif dan memperkuat kesadaran remaja terhadap pentingnya zat gizi, terutama zat besi, dalam masa pertumbuhan. Edukasi yang menarik, partisipatif, dan kontekstual terbukti menjadi pendekatan yang efektif dalam promosi kesehatan remaja. Oleh karena itu, kegiatan serupa sangat relevan untuk diadopsi secara luas sebagai upaya pencegahan anemia dan peningkatan kualitas generasi muda.
Janus Kinase Inhibitors, Monoclonal Antibodies, and Fecal Microbiota Transplantation: Promising Therapies for Ulcerative Colitis Rozak, Miftahul; Katz, Michael D; Lolita, Lolita
Clinical and Pharmaceutical Sciences Journal Vol. 1 No. 2 (2025)
Publisher : Universitas Ahmad Dahlan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.12928/clips.v1i2.376

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease involving genetic, environmental, immunological, and microbial factors. Traditional treatments often fail in certain patient populations, necessitating exploration of more personalized therapies. This review aims to evaluate the efficacy, safety, and clinical potential of three emerging therapies for UC: Janus kinase (JAK) inhibitors, anti-TL1A monoclonal antibodies, and fecal microbiota transplantation (FMT). This narrative review was conducted by searching PubMed and Google Scholar for relevant peer-reviewed literature. Inclusion criteria focused on studies published in the last 10 years that investigated the mechanisms, clinical efficacy, or safety of JAK inhibitors, anti-TL1A antibodies, or FMT in UC. Both randomized controlled trials and observational studies were included. This narrative review explores emerging therapeutic strategies for ulcerative colitis, including Janus kinase inhibitors, monoclonal antibodies, and fecal microbiota transplantation. These approaches may support personalized treatment planning, particularly in patients who are refractory to conventional therapies.JAK inhibitors including tofacitinib, upadacitinib, and filgotinib demonstrated effectiveness in inducing and maintaining remission, although safety profiles varied based on selectivity. Anti-TL1A monoclonal antibodies, particularly PF-06480605 and tulisokibart, showed dual anti-inflammatory and anti-fibrotic activity, especially in patients with specific genetic biomarkers. FMT emerged as a non-pharmacological intervention capable of modulating gut microbiota and mucosal immunity, contributing to clinical and endoscopic remission in patients refractory to standard treatments. These three therapeutic modalities represent a significant shift toward individualized, pathophysiology-based treatment of UC. Future research should focus on biomarker-guided therapy selection, optimization of FMT protocols, and long-term safety data to support integration into clinical practice. Keywords: Fecal microbiota transplantation, janus kinase inhibitors, monoclonal antibodies, ulcerative colitis
Co-Authors Chotimah, Aditya Nurul Fathurohman SW, Oman Hari Susanti Heldin, Siti Salamiah Putri Katz, Michael D Lolita Lolita Nina Salamah Pratiwi, Tiara Bella Saraswati, Damai Ira